CompletedNot applicableNCT05568524
Resistance Training With Blood Flow Restriction in Hemophilia
Studying Moderate hemophilia A
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Valencia
- Principal Investigator
- Sofía Pérez AlendaUniversity of Valencia
- Intervention
- BFRT(other)
- Enrollment
- 20 enrolled
- Eligibility
- 18-60 years · MALE
- Timeline
- 2024 – 2026
Study locations (1)
- Facultat de Fisioteràpia, Valencia, Valencia, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05568524 on ClinicalTrials.govOther trials for Moderate hemophilia A
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT05022459Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab ProphylaxisWayne State University
- RECRUITINGPHASE1, PHASE2NCT04676048ASC618 Gene Therapy in Hemophilia A PatientsASC Therapeutics
- ACTIVE NOT RECRUITINGPHASE4NCT05181618A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab ProphylaxisHoffmann-La Roche